Schizophrenia is a chronic mental disorder that affects behavior, feelings, and thinking. The condition has a strong genetic basis that influences the risk of developing the disease and the probable age of onset. As part of the genetic test, an analysis of 4 genetic polymorphisms (BDNF rs6265, MTHFR rs1801131, COMT rs4680, MTHFR rs1801133) is performed, providing information on an individual’s risk of developing the disease, the potential age of onset (adolescence or adulthood), and other medical insights. These insights include a predisposition to developing negative symptoms (reduced emotional capacity for new experiences, indifference, anhedonia, lack of motivation, attention deficit), the risk of developing compulsive and/or aggressive behavior, and the risk of developing more severe forms of the disease. Following the analysis of medical parameters, the test also provides information, through the analysis of 9 genes, on the most appropriate medication for schizophrenia treatment. Patients receive details on approximately 50 medications, including their mechanism of action, metabolism rate, and the necessary dosage to keep disease symptoms under control.
278.00€